Data completeness
1/8 — Limited
DISOMER (dexbrompheniramine maleate) by Merck & Co.. Approved for nasal congestion due to the common cold, hay fever, other upper repiratory allergies helps decongest sinus opening and 5 more indications.
Drug data last refreshed 5h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DISOMER (dexbrompheniramine maleate) is an oral antihistamine syrup indicated for nasal congestion, hay fever, and upper respiratory allergies. It works by blocking histamine receptors and reducing swelling of nasal passages and membranes to temporarily restore nasal breathing and alleviate allergy symptoms including runny nose, sneezing, itching, and watery eyes.
Pre-Launch
Pre-launch status indicates early-stage commercial activity with potential for growth once market entry occurs; team size and investments remain uncertain.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications (8)
Worked on DISOMER at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.